Related references
Note: Only part of the references are listed.A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
Istvan Petak et al.
NPJ PRECISION ONCOLOGY (2021)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy
Jason Toppi et al.
ANZ JOURNAL OF SURGERY (2020)
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
Jean-Jacques Grob et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Increase in constitutively active MEK1 species by introduction of MEK1 mutations identified in cancers
Emiko Kinoshita-Kikuta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy
Lillian Sun et al.
JAMA DERMATOLOGY (2019)
Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice
Philip A. Beer et al.
ANNALS OF ONCOLOGY (2019)
Cutaneous squamous cell carcinoma Management of advanced and high-stage tumors
Syril Keena T. Que et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
Yijun Gao et al.
CANCER DISCOVERY (2018)
GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth
Ling-tao Ding et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity
Caroline M. Emery et al.
MOLECULAR CANCER RESEARCH (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
Cutaneous Squamous Cell Carcinoma
Vishwas Parekh et al.
CLINICS IN LABORATORY MEDICINE (2017)
Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo
Ying Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?
Simone Ribero et al.
CURRENT OPINION IN ONCOLOGY (2017)
Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American Patient
Nataly Shtraizent et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)
Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis
Z. Jiyad et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma
Maryam M. Asgari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
MEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma
Charles H. Adelmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
Dmitri Madera et al.
CANCER PREVENTION RESEARCH (2015)
Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway
Yingshan Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
S. R. Lambert et al.
BRITISH JOURNAL OF CANCER (2014)
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer
Martina Kluth et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
Kerstin Trunzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma
Hyo Jeong Kang et al.
PLOS ONE (2013)
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
Jing Shi et al.
BMC CANCER (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway
Sandeep C. Chaudhary et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2012)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations
Christian Hafner et al.
EXPERIMENTAL DERMATOLOGY (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2
S-J. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
Lawrence R. Dearth et al.
CARCINOGENESIS (2007)
Mutations induced by ultraviolet light
GP Pfeifer et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
ER Zabarovsky et al.
ONCOGENE (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Primary care: Cutaneous squamous-cell carcinoma
M Alam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
